The Combination of Finasteride and Doxazosin Was More Effective Than Monotherapy in Benign Prostatic Hyperplasia
September 2004
in “
Evidencia actualizacion en la práctica ambulatoria
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that the combination of finasteride and doxazosina was more effective in reducing the long-term progression of benign prostatic hyperplasia compared to monotherapy. Our plain-language summary of this paper — not a Tressless recommendation.
The study conducted by Tesolin in 2004 concluded that the combination of finasteride and doxazosina was more effective than monotherapy in treating benign prostatic hyperplasia. This finding suggested that using both medications together provided better outcomes for patients compared to using either medication alone. The research highlighted the potential benefits of combination therapy in managing this condition, although specific details about the study size or methodology were not provided in the summary.
